SAN RAFAEL, Calif., Nov. 16, 2015 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Ernst & Young Global Limited awarded BioMarin CEO Jean-Jacques Bienaimé the EY Entrepreneur Of The Year® 2015 National Award in the Life Sciences category. The award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities. Jean-Jacques Bienaimé was selected by an independent panel of judges, and was honored at the EY Entrepreneur Of The Year National Awards gala on Nov. 14, 2015, the culminating event of the EY Strategic Growth Forum® in Palm Springs, California. The Forum is the nation’s premier gathering of high-growth, market-leading companies.
“This distinguished recognition of our commitment to patients with rare genetic diseases would not be possible, if it weren’t for BioMarin employees, the patients that we serve, the medical professionals with whom we partner and the communities where we operate,” said Jean-Jacques Bienaimé, Chairman and CEO of BioMarin. “Our laser-like focus on translating science from the laboratory into medical treatments for patients with rare genetic diseases allows us to make a big difference for a small number of patients, who often are children with few, if any, treatment options.”
BioMarin is one of the largest independent biotechs in the Northern California and one of the largest employers overall in Marin County, home to the biotech company since 1997. With more than 2,000 employees worldwide and growing, BioMarin is actively hiring, particularly people with medical and scientific backgrounds.
The EY Entrepreneur Of The Year Award recognizes visionary business leaders who demonstrate innovation, financial success and commitments to their communities as they create and build world-class companies. The EY Entrepreneur Of The Year Award winners are selected by an independent panel of judges from more than 250 regional award recipients. Awards for entrepreneurial excellence were given in 11 categories.
About EY Entrepreneur Of The Year®
EY Entrepreneur Of The Year® is the world’s most prestigious business awards program for entrepreneurs. The program makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global awards program of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 145 cities in more than 60 countries. ey.com/eoy.
Now in its 29th year, the program has honored the inspirational leadership of such entrepreneurs as Howard Schultz of Starbucks Coffee Company, Pierre Omidyar of eBay, Inc., and Mindy Grossman of HSN. Recent US national winners include Reid Hoffman and Jeff Weiner of LinkedIn; Hamdi Ulukaya, founder of Chobani; and Dr. David Hung, President and CEO and Chairman of Medivation.
As a Northern California award winner, BioMarin became eligible for consideration for the Entrepreneur Of The Year 2015 national program. Award winners in national categories were announced at the annual awards gala in Palm Springs, California, on November 14, 2015. The awards are the culminating event of the EY Strategic Growth Forum®, the nation’s most prestigious gathering of high-growth, market-leading companies.
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. The company's portfolio consists of five commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.BMRN.com.
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.
BioMarin® is a registered trademark of BioMarin Pharmaceutical Inc.
Contact: Investors: Traci McCarty BioMarin Pharmaceutical Inc. (415) 455-7558 Media: Debra Charlesworth BioMarin Pharmaceutical Inc. (415) 455-7451
Source:BioMarin Pharmaceutical Inc.